Logo-bi
Bioimpacts. 2020;10(3): 137-138. doi: 10.34172/bi.2020.16
PMID: 32793434        PMCID: PMC7416010

Editorial

COVID-19 clinical implications: the significance of nanomedicine

Jaleh Barar 1,2 * ORCID

Cited by CrossRef: 7


1- Speth R. An opinion on the impacts of COVID-19 worldwide. Bioimpacts. 2022;12(3):293 [Crossref]
2- Rahman M, Ahmed M, Islam M, Khan M, Sultana S, Maeesa S, Hasan S, Hossain M, Ferdous K, Mathew B, Rauf A, Uddin M. Nanotechnology-based Approaches and Investigational Therapeutics against COVID-19. CPD. 2022;28(12):948 [Crossref]
3- Albaz A, Rafeeq M, Sain Z, Almutairi W, Alamri A, Aloufi A, Almalki W, Tarique M. Nanotechnology-based approaches in the fight against SARS-CoV-2. AIMSMICRO. 2021;7(4):368 [Crossref]
4- Vahedifard F, Chakravarthy K. Nanomedicine for COVID-19: the role of nanotechnology in the treatment and diagnosis of COVID-19. emergent mater. 2021;4(1):75 [Crossref]
5- Varahachalam S, Lahooti B, Chamaneh M, Bagchi S, Chhibber T, Morris K, Bolanos J, Kim N, Kaushik A. Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects. IJN. 2021;Volume 16:539 [Crossref]
6- Zhu W, Wei Z, Han C, Weng X. Nanomaterials as Promising Theranostic Tools in Nanomedicine and Their Applications in Clinical Disease Diagnosis and Treatment. Nanomaterials. 2021;11(12):3346 [Crossref]
7- Wang Y, Hao Y, Fa S, Zheng W, Yuan C, Wang W. Nanomedicine for the Diagnosis and Therapy of COVID-19. Front Bioeng Biotechnol. 2021;9 [Crossref]


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge